Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bone protein boosts dental implant success in new trial

NCT ID NCT07240493

Disease control Sponsor: Aya Adil Saeed Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding a bone growth protein (rhBMP-2) to dental implants placed right after tooth removal improves implant stability and preserves jawbone. Twenty-four adults with damaged upper front or premolar teeth received either the protein or standard implant placement. Results showed better implant stability and less bone loss in the protein group, suggesting it may help implants integrate more successfully.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

24 people

The number who actually took part.

Started

Dec 2024

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy patients ≥18 years of either sex * Having a single or multiple unrestorable maxillary anterior and premolar teeth indicated for extraction * Jumping gap ≥2 mm * Apical bone ≥3 mm from the vertical structure beyond the apex * Willing to comply with the study and provide informed consent * Good oral hygiene Exclusion Criteria: * Active infection or inflammation in implant area * Uncontrolled diabetes or coagulation disorders * Immunocompromised patients * Patients treated with bisphosphonate drugs * Psychiatric problems * Pregnant women * Medical conditions affecting bone healing * Clinical evidence of parafunctional habits * Heavy smokers (≥20 cigarettes/day)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alveolar ridge resorption after extraction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Tooth Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alveolar ridge resorption after extraction Tooth extraction Tooth loss Unrestorable tooth replaced by immediate implant with BMP

Contacts and locations

Locations

  • University of Baghdad - College of Dentistry

    Baghdad, Baghdad Governorate, 10001, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.